Processa Pharmaceuticals Files Prospectus For Offering 306.574M Common Shares On Behalf Of Selling Shareholders

Processa Pharmaceuticals has filed a prospectus for the offering of 306.574 million common shares on behalf of selling shareholders. This move is aimed at facilitating liquidity for the shareholders. The stock is traded under the ticker PCSA.